Cardiac and vascular remodelling: Effect of antihypertensive agents

Journal of Human Hypertension

Volumn 13, Issue , 1999, Pages S35-S41

  Mallion, Jean Michel ^a   Baguet, J P ^a   Siche, J P ^a   Tremel, F ^a   de Gaudemaris, R ^a  

^a Med Interne et Cardiologie   (France)

Author keywords

Antihypertensive treatment; Blood pressure; Concentric remodelling; Hypertension; Hypertrophy; Left ventricle

Indexed keywords

ACEBUTOLOL; AMLODIPINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DOXAZOSIN; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; ISRADIPINE; PRAZOSIN; VERAPAMIL; ANGIOTENSIN RECEPTOR;

ANIMAL MODEL; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; CAROTID ARTERY; CLINICAL TRIAL; CONFERENCE PAPER; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PROGNOSIS; REFERENCE VALUE; TARGET ORGAN; ANIMAL; BLOOD PRESSURE; BLOOD VESSEL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VESSELS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; PRACTICE GUIDELINES; RECEPTORS, ANGIOTENSIN; RETROSPECTIVE STUDIES; VENTRICULAR REMODELING; WORLD HEALTH ORGANIZATION;

EID: 0032609921     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000755     Document Type: Article

References (48)

1. The sixth report of the Joint National Committee on prevention, detection, and treatment of high blood pressure. NIH Publication No. 98-4080, 1997.
2. Orcel L, Chomette G. Anatomie pathologique vasculaire. Flammarion Médecine Sciences: Paris, 1978.
3. Nichols WW, O’Rourke MF. McDonald’s blood flow in arteries. 3rd edn. Edt Lea and Febiger: Philadelphia, London, 1990.
4. O’Rourke MF, Kelly R, Avolio A. The Arterial Pulse. Lea and Febiger: Philadelphia, London, 1992.
5. Urata H, Nishimura H, Ganten D. Mechanisms of angiotensin II formation in humans. European Heart J1995: 16 (Suppl N): 79-85.
6. Girerd X Noninvasive ultrasound methods for the measurement of arterial wall thickness. In: Touboul PJ (ed). Intima-media thickness and atherosclerosis. Predicting the risk? Parthenon Publishing Group: NY USA and Lanes UK, 1997, pp 45-57.
7. De Simone G, Ganau A, Verdecchia P, Devereux RB. Echocardiography in arterial hypertension: when, why and how? J Hypertens 1994; 12: 1129-1136.
8. Salomon R, Haapanen A, Salonen JT. Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Bio1991: 17: 225-230.
9. Devereux RB Standardization of M-mode echo- cardiographic left ventricular anatomic measurements.; Am Coll Cardiol 1984; 4: 1222-1230.
10. Ganau A Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension.; Am Coll Cardiol 1992; 12: 1550-1556.
11. Päivänsalo M Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound. J Hypertens 1996; 14: 1433-1439.
12. Botouyrie P Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. J Hypertens 1995; 25: 651-659.
13. Roman MJ Prevalence and determinants of cardiac and vascular hypertrophy in hypertension. J Hypertens 1995; 26: 359-373.
14. Baguet JP Cardiac and vascular remodeling in never treated hypertensive subjects selected on ambulatory blood pressure measurement data. To be published.
15. Salonen TJ, Salonen R. Ultrasonographic 5-mode imaging in observational studios of atherosclerotic progression. Circulation 1993; 87 (Suppl 3): 58-65.
16. Roman MJ Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol1995; 25: 83-90.
17. Cuspidi C Left ventricular concentric remodeling and carotid structural changes in essential hypertension. J Hypertens 1998: 14: 1441-1446.
18. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245-1249.
19. Roman MJ Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1986; 28: 751-756.
20. Roman MJ Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909- 1918.
21. Hughes AD Structural changes in the heart and carotid arteries associated with hypertension in humans. J Hum Hypertens 1993; 7: 395-397.
22. Tice FD Vascular hypertrophy is an early finding in essential hypertension and is related to arterial pressure waveform, contour. Am Heart J 1996; 132: 821-827.
23. Siché JP 24 hour ambulatory pulse pressure is an independent predictor of the cardiac and vascular radial artery, structural adaptation. Poster presentation. Eighth European Meeting on Hypertension, Milan, 1997. To be published.
24. Boutouyrie P Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1996; 25: 651-669.
25. Gariepy J Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993; 22: 111-118.
26. Safar ME, Girerd X, Laurent S. Structural changes of large conduit arteries in hypertension. J Hypertens1996; 14: 545-555.
27. Houghton JL Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol1990; 15: 43-51.
28. Treasure CB Hypertension and left ventricular hypertrophy are associated with impaired endo- thelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 37: 86-93.
29. Anthony I, Nitenberg A, Fault JM, Aptear E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993; 22: 514-520.
30. Schwartzkopff B Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993-1003.
31. Young W, Gofman JW, Tandy R. The quantitation of atherosclerosis. Quantitative aspects of the relationship of blood pressure and atherosclerosis. Am J Cardiol 1960; 6: 294-299.
32. Levy O Risk of ventricular arrhythmias in left ventricular hypertrophy; the Framingham Heart Study. Am J Cardiol 1987; 60: 560-565.
33. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317: 782-792.
34. Ghah JK, Kaoakia S, Cooper RS, Liao Y. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol 1991; 17: 1277-1282.
35. Koyanagi S, Eastharm CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982; 50: 55-62.
36. Bikkina M Left ventricular mass and risk of stroke in an elderly cohort: The Framingham Heart Study. JAMA 1994; 272: 33-36.
37. Blake J Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol 1988; 62: 246-252.
38. Bonithon-Kopp C. Prevalence of and risk factors for intima-media thickening: a literature review. In: Tou- boul PJ (ed). Intima-media thickness and atherosclerosis. Predicting the risk? Parthenon Publishing Group: NY USA and Lanes UK, 1997, pp 27-44.
39. Salonen TJ, Salonen R. Arterial wall thickness, carotid atherosclerosis and the risk of myocardial infarction and cerebrovascular stroke. In: Touboul PJ (ed). Intima-media thickness and atherosclerosis. Predicting the risk? Parthenon Publishing Group: NY USA and Lanes UK, 1997, pp 97-104.
40. Crouse JR. Association of arterial wall thickening and coronary disease. In: Touboul PJ (ed). Intima-media thickness and atherosclerosis. Predicting the risk? Parthenon Publishing Group: NY USA and Lanes UK, 1997, pp 105-115.
41. Bots ML, Grobbee DE. Carotid intima-media thickness and atherosclerosis in the lower extremities. In: Tou- boul PJ (ed). Intima-media thickness and atherosclerosis. Predicting the risk? Parthenon Publishing Group: NY USA and Lanes UK, 1997, pp 117-126.
42. Dahlöf FB, Panned K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens1992; 5: 95-110.
43. Schmieder RE, Manus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. JAMA 1996; 275: 19.
44. Neanton JD Treatment of mild hypertension study. Final results. JAMA 1993; 270: 713-724.
45. Gottdiener JD For the VA Cooperative Study Group on Antihypertensive Agents. Effect of singledrug therapy on reduction of left ventricular mass in mild to moderate hypertension. Comparison of six antihypertensive agents. Circulation 1997; 95: 2007- 2014.
46. Borhani NO Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS). JAMA 1996; 276: 785-791.
47. Koren MJ Changes in left ventricular mass to predict risk in essential hypertension. Circulation 1990; 82 (Suppl III): 29 (abstr).
48. Muiesan ML Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up. J Hypertens 1996; 14 (Suppl 5): S43-S49.